Agency for Health Care Policy and Research (AHCPR). Health Technology Reports: intermittent positive pressure breathing (IPPB) therapy. 1991, Number 1.
2.
The IPPB Trial Group. Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med1983;99:612–620.
3.
OstrowDN. Managing chronic airflow obstruction. Part II. Geriatrics1985;40(3):51–53,56–59 passim.
4.
GonzalezER, BurkeTG. Review of the status of intermittent positive pressure breathing therapy. Drug Intell Clin Pharm1984;18:974–976.
5.
PedersenJZ, BundgaardA.Comparative efficacy of different methods of nebulising terbutaline. Eur J Clin Pharmacol1983;25:739–742.
6.
WeberRW, PettyWE, NelsonHS. Aerosolized terbutaline in asthmatics: comparison of dosage strength, schedule, and method of administration. J Allergy Clin Immunol1979;63:116–121.
7.
MooreRB, CottonEK, PinneyMA. The effect of intermittent positive-pressure breathing on airway resistance in normal and asthmatic children. J Allergy Clin Immunol1972;49:137–141.
8.
DolovichMB, KillianD, WolffRK, ObminskiG, NewhouseMT. Pulmonary aerosol deposition in chronic bronchitis: intermittent positive pressure breathing versus quiet breathing. Am Rev Respir Dis1977;115:397–402.
9.
BartlettRH, GazzanigaAB, GeraghtyTR. Respiratory maneuvers to prevent postoperative pulmonary complications: a critical review. JAMA1973;224:1017–1021.
10.
BartlettRH. Respiratory therapy to prevent pulmonary complications of surgery. Respir Care1984;29(6):667–679.
11.
MariniJJ. Postoperative atelectasis: pathophysiology, clinical importance, and principles of management. Respir Care1984;29(5):516–528.
12.
American Thoracic Society (ATS). As quoted in Intermittent Positive Pressure Breathing Therapy. AHCPR Health Technology Assessment Reports, 1991, No. 1:5.
13.
National Association of Medical Directors of Respiratory Care (NAMDRC). As quoted in Intermittent Positive Pressure Breathing Therapy. AHCPR Health Technology Assessment Reports, 1991, No. 1:6.
14.
American College of Chest Physicians (ACCP). As quoted in Intermittent Positive Pressure Breathing Therapy. AHCPR Health Technology Assessment Reports, 1991, No. 1:6.
15.
De TroyerA, DeisserP.The effects of intermittent positive pressure breathing on patients with respiratory muscle weakness. Am Rev Respir Dis1981;124(2):132–137.
16.
RodensteinDO, StanescuDC, DelgusteP, LiistroG, Aubert-TulkensG.Adaptation to intermittent positive pressure ventilation applied through the nose during day and night. Eur Respir J1989;2(5):473–478.
17.
BrochardL, HarfA, LorinoH, LemaireF.Inspiratory pressure support prevents diaphragmatic fatigue during weaning form mechanical ventilation. Am Rev Respir Dis1989;139(2):513–521.
18.
McKimDA, DalesRE, LefebvreGG, ProulxM.Nocturnal positive-pressure nasal ventilation for respiratory failure during pregnancy. Can Med Assoc J1988;139(11):1069–1071.
19.
BachJR, AlbaA, MosherR, DelaubierA.Intermittent positive pressure ventilation via nasal access in the management of respiratory insufficiency. Chest1987;92(1):168–170.
20.
KinnearWJ, ShneersonJM. Assisted ventilation at home: is it worth considering?Br J Dis Chest1985;79(4):313–351.
21.
SplaingardML, FratesRCJr, JeffersonLS, RosenCL, HarrisonGM. Home negative pressure ventilation report of 20 years of experience in patients with neuromuscular disease. Arch Phys Med Rehabil1985;66(4):239–242.
22.
FergussonRJ, CarmichaelJ, RaffertyP, WilleyRF, CromptonGK, GrantIW. Nebulized salbutamol in life-threatening asthma. Is IPPB necessary?Br J Dis Chest1983;77:255–261.
23.
LorenM, ChaiH, MiklichD, BarwiseG.Comparison between simple nebulization and intermittent positive-pressure in asthmatic children with severe bronchospasm. Chest1977;72:145–147.
24.
PattersonJW. A comparison of three different techniques for giving nebulized albuterol to asthmatic patients. Am Rev Respir Dis1974;110:293–300.
25.
EggertsenSC. Intermittent positive pressure breathing and the treatment of acute asthma. J Fam Pract1983;16:909–913.
26.
Choo-KangYF, GrantIW. Comparison of two methods of administering bronchodilator aerosol to asthmatic patients. Br Med J1975;2:119–120.
27.
AelonyY.“Noninvasive” oral treatment of asthma in the emergency room. Am J Med1985;78(6, Part 2):929–936.
28.
CaytonRM, WebberB, PatersonJW, ClarkTJ. A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma. Br J Dis Chest1978;72:222–224.
29.
WebberBA, CollinsJV, BranthwaiteMA. Severe acute asthma: a comparison of three methods of inhaling salbutamol. Br J Dis Chest1982;76:69–74.
30.
ChangN, LevisonH.The effect of a nebulized bronchodilator administered with or without intermittent positive pressure breathing on ventilatory function in children with cystic fibrosis and asthma. Am Rev Respir Dis1972;106:867–872.
31.
BranscombBV. Metaproterenol solution in the treatment of asthmatic patients by intermittent positive pressure breathing. J Clin Pharmacol1982;22:231–235.
32.
AndersonPB, GoudeA, PeakeMD. Comparison of salbutamol given by intermittent positive-pressure breathing and pressure-packed aerosol in chronic asthma. Thorax1982;37:612–616.
33.
WebberBA, ShenfieldGM, PatersonJW. A comparison of three different techniques for giving nebulized albuterol to asthmatic patients. Am Rev Respir Dis1974;109:293–295.
34.
ShapiroBA, PetersonJ, CarneRD. Complications of mechanical aids to intermittent lung inflation. Respir Care1982;27(4):467–470.
35.
SchillingJP, KasikJE. Intermittent positive pressure breathing: a continuing controversy. J Iowa Med Soc1980;70:99–100,102–103.
36.
BransonRD, CampbellRS. Sighs: wasted breath or breath of fresh air?Respir Care1992;37(5):462–468.
37.
NewmanSP. Aerosol deposition considerations in inhalation therapy. Chest1985;88(2, Suppl):152S–160S.
38.
TashkinDP. Dosing strategies for bronchodilator aerosol delivery. Respir Care1991;36(9):977–988.
39.
NelsonHS, SpectorSL, WhitsettTL, GeorgeRB, DwekJH. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol1983;72:371–375.
40.
DolovichM.Clinical aspects of aerosol physics. Respir Care1991;36(9):931–938.
41.
KacmarekRM, HessD.The interface between patient and aerosol generator. Respir Care1991;36(9):952–976.
42.
American Association for Respiratory Care. Clinical practice guideline: selection of aerosol delivery device. Respir Care1992;37(8):891–897.
43.
AllenSC, PriorA.What determines whether an elderly patient can use a metered dose inhaler correctly?Br J Dis Chest1986;80:45–49.
44.
LindgrenS, BakeB, LarssonS.Clinical consequences of inadequate inhalation technique in asthma therapy. Eur J Respir Dis1987;70:93–98.
45.
OrehekJ, GayrardP, GrimaudC, CharpinJ.Patient error in use of bronchodilator metered aerosols. Br Med J1976;1:76.
46.
GuidryGG, BrownWD, StognerSW, GeorgeRB. Incorrect use of metered does inhalers by medical personnel. Chest1992;101:31–33.
47.
CromptonGK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis1982;119(Suppl):101–104.
48.
O'ConnellMB, HewittJM, LacknerTE. Consistency of evaluators assessing inhaler technique. Ann Allergy1991;67:603–608.
49.
De TullioPL, CorsonME. Effect of pharmacist counseling on ambulatory patients' use of aerosolized bronchodilators. Am J Hosp Pharm1987;44:1802–1806.
50.
SelfTH, BrooksJB, LiebermanP, RyanMR. The value of demonstration and role of the pharmacist in teaching the correct use of pressurized bronchodilators. Can Med Assoc J1983;128:129–131.
51.
WoodcockA.Training aid for pressurized inhalers. Br J Dis Chest1980;74:395–397.
52.
SterkPJ, PlompA, van de VateJF, QuanjerPH. Physical properties of aerosols produced by several jet- and ultrasonic nebulisers. Bull Eur Physiopathol Respir1984;20:65–72.
53.
AlvineGF, RodgersP, FitzsimmonsKM, AhrensRC. Disposable jet nebulizers: how reliable are they?Chest1992;101:316–319.
54.
NewmanSP. Aerosol generators and delivery systems. Respir Care1991;36(9):939–951.
55.
MestitzH, CoplandJM, McDonaldCF. Comparison of outpatient nebulized vs metered dose inhaler terbutaline in chronic airflow obstruction. Chest1989;96:1237–1240.
56.
BowtonDL, GoldsmithWM, HaponikEF. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest1992;101:305–308.
57.
TenholderMF, BrysonMJ, WhitlockWL. A model for conversion from small volume nebulizer to metered dose inhaler aerosol therapy. Chest1992;101:634–637.
58.
JasperAC, MohsenifarZ, KahanS, GoldbergHS, KoernerSK. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest1987;91:614–618.
59.
SummerW, ElstonR, TharpeL, NelsonS, HaponikEF. Aerosol bronchodilator delivery methods: relative impact on pulmonary function and cost of respiratory care. Arch Intern Med1989;149:618–623.
60.
SchoonoverG, OlsenGN. Pulmonary function testing in the preoperative period: a review of the literature. J Clin Surg1982;1:125–138.
61.
RuffinRE, KenworthyMC, NewhouseMT. Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose. Clin Pharmacol Ther1978;23:338–345.
62.
BerryRR, ShintoRA, WongFH, DesparsJA, LightRW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest1989;96:1241–1246.
63.
Centers for Disease Control. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in health-care settings. MMWR1988;37:377–388.
64.
Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR1990;37(RR-17):1–29.
65.
BradyMT. Nosocomial Legionnaires disease in a children's hospital. J Pediatr1989;115(1):46–50.
66.
MastroTD, FieldsBS, BreimanRF, CampbellJ, PlikaytisBD, SpikaJS. Nosocomial Legionnaires' disease and use of medication nebulizers. J Infect Dis1991;162(3):667–671.
67.
JenkinsSC, HeatonRW, FultonTJ, MoxhamJ.Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest1987;91:804–807.
68.
SacknerMA, KimCS. Recent advances in the management of obstructive airways disease: auxiliary MDI aerosol delivery systems. Chest1985;88(2, Suppl):161S–169S.
69.
O'ReillyJF, GouldG, KendrickAH, LaszloG.Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma. Thorax1986;41:766–770.
70.
CissikJH, BodeFR, SmithJA. Double-blind crossover study of five bronchodilator medications and two delivery methods in stable asthma: is there a best combination for use in the pulmonary laboratory?Chest1986;90:489–493.
71.
MorganMDL, SinghBV, FrameMH, WilliamsSJ. Terbutaline aerosol given through pear spacer in acute severe asthma. Br Med J Clin Res Ed1982;285:849–850.
LevisonH, ReillyPA, WorsleyGH. Spacing devices and metered dose inhalers in childhood asthma. J Pediatr1985;107:662–668.
74.
TurnerJR, CorkeryKJ, EckmanD, GelbAM, LipavskyA, SheppardD.Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute air-flow obstruction. Chest1988;93:476–481.
